Concepedia

Akash Mitra

AM

Statistics

Publications

5

Citations

532

H-Index

5

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AstraZeneca (United States)

Quantitative BioSciences

Akash Mitra is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2002–2022

5

Publications

5

Immuno-genomic landscape of osteosarcoma

Chia-Chin Wu, Hannah C. Beird, J. Andrew Livingston et al. · Nature Communications · 2020 · 244 citations · Full text

, , +17

Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial

Neeta Somaiah, Anthony P. Conley, Edwin R. Parra et al. · The Lancet Oncology · 2022 · 157 citations

, , +16

Evaluation of chemical constituents and free-radical scavenging activity of Swarnabhasma (gold ash), an ayurvedic drug

Akash Mitra, Sulagna Chakraborty, Biswajit Auddy et al. · Journal of Ethnopharmacology · 2002 · 88 citations

, , +10

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma

Akash Mitra, Miles C. Andrews, Whijae Roh et al. · Nature Communications · 2020 · 26 citations · Full text

, , +17

B‐cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T‐cell precursor acute lymphoblastic leukaemia/lymphoma (ETP‐ALL/LBL) from other subtypes of T‐cell ALL/LBL

Hong Fang, Wei Wang, Siba El Hussein et al. · British Journal of Haematology · 2021 · 17 citations · Full text

, , +17

1–5 of 5